Ergoteles’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,339
| Closed | -$1.07M | – | 280 |
|
|
2023
Q2 | $1.07M | Buy |
8,339
+2,181
| +35% | +$280K | 0.05% | 447 |
|
|
2023
Q1 | $715K | Sell |
6,158
-120,423
| -95% | -$14M | 0.03% | 615 |
|
|
2022
Q4 | $14.3M | Buy |
126,581
+67,410
| +114% | +$7.63M | 0.53% | 34 |
|
|
2022
Q3 | $4.77M | Sell |
59,171
-115,406
| -66% | -$9.3M | 0.17% | 122 |
|
|
2022
Q2 | $13M | Buy |
174,577
+167,853
| +2,496% | +$12.5M | 0.39% | 62 |
|
|
2022
Q1 | $860K | Buy |
6,724
+2,536
| +61% | +$324K | 0.03% | 481 |
|
|
2021
Q4 | $562K | Buy |
+4,188
| New | +$562K | 0.02% | 598 |
|
|
2021
Q1 | – | Sell |
-2,400
| Closed | -$222K | – | 858 |
|
|
2020
Q4 | $222K | Buy |
+2,400
| New | +$222K | 0.01% | 585 |
|